Mechanisms of pulmonary fibrosis

Annual Review of Medicine

Volumn 55, Issue , 2004, Pages 395-417

  Thannickal, Victor J ^a   Toews, Galen B ^a   White, Eric S ^a   Lynch III, Joseph P ^a   Martinez, Fernando J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Cell differentiation; Fibroblasts; Inflammation; Regeneration

Indexed keywords

CYTOKINE; GAMMA INTERFERON; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

AGE; ANGIOGENESIS; APOPTOSIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL PROLIFERATION; DISEASE COURSE; EFFECTOR CELL; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EPITHELIZATION; EXTRACELLULAR MATRIX; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HOST; HUMAN; IDIOPATHIC DISEASE; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS; LUNG FIBROSIS; MYOFIBROBLAST; NEUTROPHIL; OXIDATIVE STRESS; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; REVIEW; TISSUE INJURY; TISSUE REPAIR;

HUMANS; LUNG; PULMONARY FIBROSIS;

EID: 1542329010     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.55.091902.103810     Document Type: Review

References (182)

1. Katzenstein AL, Myers JL. 1998. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157:1301-15
2. American Thoracic Society/European Respiratory Society International Multi-disciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. 2002. Am. J. Respir. Crit. Care Med. 165:277-304
3. Selman M, King TE, Pardo A. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-51
4. Collard HR, King TE Jr. 2003. Demystifying idiopathic interstitial pneumonia. Arch. Intern. Med. 163:17-29
5. Flaherty KR, Travis WD, Colby TV, et al. 2001. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med. 164:1722-27
6. Katzenstein AL, Zisman DA, Litzky LA, et al. 2002. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am. J. Surg. Pathol. 26:1567-77
7. Flaherty KR, Colby TV, Travis WD, et al. 2003. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am. J. Respir. Crit. Care Med. 167:1410-15
8. Thomas AQ, Lane K, Phillips J 3rd, et al. 2002. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular non-specific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165:1322-28
9. Nathan C. 2002. Points of control in inflammation. Nature 420:846-52
10. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301-5
11. Lawrence T, Gilroy DW, Colville-Nash PR, et al. 2001. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7:1291-97
12. Wahl SM, Hunt DA, Wakefield LM, et al. 1987. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84:5788-92
13. Grande JP. 1997. Role of transforming growth factor-β in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 214:27-40
14. Coalson JJ. 1982. The ultrastructure of human fibrosing alveolitis. Virchows Arch. A Pathol. Anat. Histol. 395:181-99
15. Corrin B, Jagusch M, Dewar A, et al. 1987. Fine structural changes in idiopathic pulmonary haemosiderosis. J. Pathol. 153:249-56
16. Kasper M, Haroske G. 1996. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol. Histopathol. 11:463-83
17. Rennard SI, Bitterman PB, Crystal RG. 1983. Response of the lower respiratory tract to injury. Mechanisms of repair of the parenchymal cells of the alveolar wall. Chest 84:735-39
18. Katzenstein AL. 1985. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. Hum. Pathol. 16:1015-24
19. Martin P. 1997. Wound healing - aiming for perfect skin regeneration. Science 276:75-81
20. Chilosi M, Poletti V, Murer B, et al. 2002. Abnormal re- epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab. Invest. 82:1335-45
21. Adamson IY, Young L, Bowden DH. 1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130:377-83
22. Sakai T, Satoh K, Matsushima K, et al. 1997. Hepatocyte growth factor in bronchoalveolar lavage fluids and cells in patients with inflammatory chest diseases of the lower respiratory tract: detection by RIA and in situ hybridization. Am. J. Respir. Cell Mol. Biol. 16:388-97
23. Hojo S, Fujita J, Yoshinouchi T, et al. 1997. Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis. Respir. Med. 91:511-16
24. Christensen PJ, Bailie MB, Goodman RE, et al. 2000. Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 279:L487-95
25. Moore BB, Coffey MJ, Christensen P, et al. 2000. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J. Immunol. 165:4032-39
26. -/- mice: implications for fibroproliferation. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L1103-11
27. Xing Z, Tremblay GM, Sime PJ, et al. 1997. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-β 1 and myofibroblast accumulation. Am. J. Pathol. 150:59-66
28. Chen G, Grotendorst G, Eichholtz T, et al. 2003. GM-CSF increases airway smooth muscle cell connective tissue expression by inducing TGF-β receptors. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L548-56
29. Maeyama T, Kuwano K, Kawasaki M, et al. 2001. Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 17:180-89
30. Wang R, Zagariya A, Ang E, et al. 1999. Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction. Am. J. Physiol. Lung Cell Mol. Physiol. 277:L1245-50
31. Wang R, Ramos C, Joshi I, et al. 1999. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am. J. Physiol. Lung Cell Mol. Physiol. 277:L1158-64
32. Hagimoto N, Kuwano K, Inoshima I, et al. 2002. TGF-β 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J. Immunol. 168:6470-78
33. Kuwano K, Hagimoto N, Maeyama T, et al. 2002. Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab. Invest. 82:1695-706
34. Lavrentiadou SN, Chan C, Kawcak T, et al. 2001. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione. Am. J. Respir. Cell Mol. Biol. 25:676-84
35. 2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J. Cell Sci. 111(Pt. 21):3209-20
36. Beeh KM, Beier J, Haas IC, et al. 2002. Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 19:1119-23
37. Cantin AM, Hubbard RC, Crystal RG. 1989. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139:370-72
38. Arsalane K, Dubois CM, Muanza T, et al. 1997. Transforming growth factor-β1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH ratelimiting enzyme γ-glutamylcysteine synthetase. Am. J. Respir. Cell Mol. Biol. 17:599-607
39. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor β1. J. Biol. Chem. 270:30334-38
40. Crouch E. 1990. Pathobiology of pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 259:L159-84
41. Kuwano K, Hagimoto N, Kawasaki M, et al. 1999. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104:13-19
42. Hagimoto N, Kuwano K, Miyazaki H, et al. 1997. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell Mol. Biol. 17:272-78
43. Kunugi S, Fukuda Y, Ishizaki M, et al. 2001. Role of MMP-2 in alveolar epithelial cell repair after bleomycin administration in rabbits. Lab. Invest. 81:1309-18
44. Parks WC, Shapiro SD. 2001. Matrix metalloproteinases in lung biology. Respir. Res. 2:10-19
45. Hayashi T, Stetler-Stevenson WG, Fleming MV, et al. 1996. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am. J. Pathol. 149:1241-56
46. Selman M, Ruiz V, Cabrera S, et al. 2000. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing non-degradative lung microenvironment? Am. J. Physiol. Lung Cell Mol. Physiol. 279:L562-74
47. Dunsmore SE, Saarialho-Kere UK, Roby JD, et al. 1998. Matrilysin expression and function in airway epithelium. J. Clin. Invest. 102:1321-31
48. Zuo F, Kaminski N, Eugui E, et al. 2002. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. USA 99:6292-97
49. Eitzman DT, McCoy RD, Zheng X, et al. 1996. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J. Clin. Invest. 97:232-37
50. Sisson TH, Hanson KE, Subbotina N, et al. 2002. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 283: L1023-32
51. Otto WR. 2002. Lung epithelial stem cells. J. Pathol. 197:527-35
52. Poulsom R, Alison MR, Forbes SJ, et al. 2002. Adult stem cell plasticity. J. Pathol. 197:441-56
53. Kotton DN, Ma BY, Cardoso WV, et al. 2001. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128:5181-88
54. Theise ND, Henegariu O, Grove J, et al. 2002. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp. Hematol. 30:1333-38
55. Krause DS, Theise ND, Collector MI, et al. 2001. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-77
56. Davies JC, Potter M, Bush A, et al. 2002. Bone marrow stem cells do not repopulate the healthy upper respiratory tract. Pediatr. Pulmonol. 34:251-56
57. Khalil N, O'Connor RN, Unruh UW, et al. 1991. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:155-62
58. Kapanci Y, Desmouliere A, Pache JC, et al. 1995. Cytoskeletal protein modulation in pulmonary alveolar myofibroblasts during idiopathic pulmonary fibrosis. Possible role of transforming growth factor β and tumor necrosis factor α. Am. J. Respir. Crit. Care Med. 152:2163-69
59. Khalil N, O'Connor RN, Flanders KC, et al. 1996. TGF-β 1, but not TGF-β 2 or TGF-β 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am. J. Respir. Cell Mol. Biol. 14:131-38
60. Antoniades HN, Neville-Golden J, Galanopoulos T, et al. 1992. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 89: 5371-75
61. Antoniades HN, Bravo MA, Avila RE, et al. 1990. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J. Clin. Invest. 86:1055-64
62. Nash JR, McLaughlin PJ, Butcher D, et al. 1993. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. Histopathology 22:343-41
63. Pan LH, Yamauchi K, Uzuki M, et al. 2001. Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur. Respir. J. 17:1220-27
64. Giaid A, Michel RP, Stewart DJ, et al. 1993. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 341:1550-54
65. Wilborn J, Crofford LJ, Burdick MD, et al. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest 95:1861-68
66. Borok Z, Gillissen A, Buhl R, et al. 1991. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am. Rev. Respir. Dis. 144:1080-84
67. Folkerts G, Nijkamp FP. 1998. Airway epithelium: more than just a barrier! Trends Pharmacol. Sci. 19:334-41
68. Wang R, Ghahary A, Shen YJ, et al. 1997. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts. J. Invest. Dermatol. 108:438-44
69. Vernet D, Ferrini MG, Valente EG, et al. 2002. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 7:262-76
70. 1. Am. J. Respir. Cell Mol. Biol. 21:658-65
71. Kuhn C, McDonald JA. 1991. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 138:1257-65
72. King TE Jr., Schwarz MI, Brown K, et al. 2001. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 164:1025-32
73. Nicholson AG, Fulford LG, Colby TV, et al. 2002. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166:173-77
74. Gabbiani G, Ryan GB, Majne G. 1971. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 27:549-50
75. Walker GA, Guerrero IA, Leinwand LA. 2001. Myofibroblasts: molecular cross-dressers. Curr. Top. Dev. Biol. 51:91-107
76. Kuhn C 3rd, Boldt J, King TE Jr., et al. 1989. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 140:1693-703
77. Zhang K, Rekhter MD, Gordon D, et al. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145:114-25
78. Tomasek JJ, Gabbiani G, Hinz B, et al. 2002. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3:349-63
79. Harris J. 1994. Differentiated cells and the maintenance of tissues. In Molecular Biology of the Cell, ed. B Alberts, D Bray, J Lewis, et al., pp. 1139-93. New York: Garland
80. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N. Engl. J. Med. 341:738-46
81. Desmouliere A, Redard M, Darby I, et al. 1995. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146:56-66
82. Lorena D, Uchio K, Costa AM, et al. 2002. Normal scarring: importance of myofibroblasts. Wound Repair Regen. 10:86-92
83. Grinnell F, Zhu M, Carlson MA, et al. 1999. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp. Cell Res. 248:608-19
84. Border WA, Noble NA. 1994. Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331:1286-92
85. Phan SH. 2002. The myofibroblast in pulmonary fibrosis. Chest 122:286S-289S
86. Pittenger MF, Mackay AM, Beck SC, et al. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-47
87. Iwano M, Plieth D, Danoff TM, et al. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:341-50
88. Shahar I, Fireman E, Topilsky M, et al. 1999. Effect of endothelin-1 on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases. Int. J. Immunopharmacol. 21:759-75
89. Bogatkevich GS, Tourkina E, Silver RM, et al. 2001. Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J. Biol. Chem. 276:45184-92
90. Serini G, Bochaton-Piallat ML, Ropraz P, et al. 1998. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J. Cell Biol. 142:873-81
91. Dugina V, Fontao L, Chaponnier C, et al. 2001. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J. Cell Sci. 114:3285-96
92. Arora PD, Narani N, McCulloch CA. 1999. The compliance of collagen gels regulates transforming growth factor-β induction of α-smooth muscle actin in fibroblasts. Am. J. Pathol. 154:871-82
93. Hinz B, Mastrangelo D, Iselin CE, et al. 2001. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am. J. Pathol. 159:1009-20
94. Thannickal VJ, Lee DY, White ES, et al. 2003. Myofibroblast differentiation by transforming growth factor-β1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278:12384-89
95. Hashimoto S, Gon Y, Takeshita I, et al. 2001. Transforming growth factor-β1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am. J. Respir. Crit. Care Med. 163:152-57
96. Raghu G, Chen YY, Rusch V, et al. 1988. Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am. Rev. Respir. Dis. 138:703-8
97. Jordana M, Schulman J, McSharry C, et al. 1988. Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. Am. Rev. Respir. Dis. 137:579-84
98. Ramos C, Montano M, Garcia-Alvarez J, et al. 2001. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am. J. Respir. Cell Mol. Biol. 24:591-98
99. Torry DJ, Richards CD, Podor TJ, et al. 1994. Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue. J. Clin. Invest. 93:1525-32
100. Lappi-Blanco E, Soini Y, Paakko P. 1999. Apoptotic activity is increased in the newly formed fibromyxoid connective tissue in bronchiolitis obliterans organizing pneumonia. Lung 177:367-76
101. Kuhn C, Mason RJ. 1995. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am. J. Pathol. 147:1759-69
102. Fukuda Y, Basset F, Ferrans VJ, et al. 1995. Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis. Hum. Pathol. 26:53-61
103. Fukuda Y, Ishizaki M, Kudoh S, et al. 1998. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78:687-98
104. Fukuda Y, Mochimaru H, Terasaki Y, et al. 2001. Mechanism of structural remodeling in pulmonary fibrosis. Chest 120:41S-43S
105. Suganuma H, Sato A, Tamura R, et al. 1995. Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax 50:984-89
106. Miki H, Mio T, Nagai S, et al. 2000. Fibroblast contractility: usual interstitial pneumonia and nonspecific interstitial pneumonia. Am. J. Respir. Crit. Care Med. 162:2259-64
107. Finlay GA, Thannickal VJ, Fanburg BL, et al. 2000. Transforming growth factor-β 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. J. Biol. Chem. 275:27650-56
108. Phan SH, Zhang K, Zhang HY, et al. 1999. The myofibroblast as an inflammatory cell in pulmonary fibrosis. Curr. Top. Pathol. 93:173-82
109. Mezzano SA, Droguett MA, Burgos ME, et al. 2000. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int. 57:147-58
110. 2 production in lung fibroblasts stimulated by transforming growth factor β1. J. Biol. Chem. 273:23611-15
111. Holstein AF, Maekawa M, Nagano T, et al. 1996. Myofibroblasts in the lamina propria of human seminiferous tubules are dynamic structures of heterogeneous phenotype. Arch. Histol. Cytol. 59:109-25
112. Brouty-Boye D, Pottin-Clemenceau C, Doucet C, et al. 2000. Chemokines and CD40 expression in human fibroblasts. Eur. J. Immunol. 30:914-19
113. Kaufman J, Graf BA, Leung EC, et al. 2001. Fibroblasts as sentinel cells: role of the CDcd40-CDcd40 ligand system in fibroblast activation and lung inflammation and fibrosis. Chest 120:53S-55S
114. Buckley CD, Pilling D, Lord JM, et al. 2001. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22:199-204
115. Lo D, Feng L, Li L, et al. 1999. Integrating innate and adaptive immunity in the whole animal. Immunol. Rev. 169:225-39
116. Selman M, Pardo A. 2002. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir. Res. 3:3
117. Davies DE, Holgate ST. 2002. Asthma: the importance of epithelial mesenchymal communication in pathogenesis. Inflammation and the airway epithelium in asthma. Int. J. Biochem. Cell Biol. 34:1520-26
118. Thannickal VJ, Aldweib KD, Rajan T, et al. 1998. Upregulated expression of fibroblast growth factor (FGF) receptors by transforming growth factor-β1 (TGF-β1) mediates enhanced mitogenic responses to FGFs in cultured human lung fibroblasts. Biochem. Biophys. Res. Commun. 251:437-41
119. Heino J, Ignotz RA, Hemler ME, et al. 1989. Regulation of cell adhesion receptors by transforming growth factor-β. Concomitant regulation of integrins that share a common β 1 subunit. J. Biol. Chem. 264:380-88
120. Gross TJ, Hunninghake GW. 2001. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 345:517-25
121. Hogaboam CM, Bone-Larson CL, Lipinski S, et al. 1999. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1-and Th2-type pulmonary granuloma models. J. Immunol. 163:2193-201
122. Hogaboam CM, Steinhauser ML, Chensue SW, et al. 1998. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int. 54:2152-59
123. Cantin AM, North SL, Fells GA, et al. 1987. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79:1665-73
124. Obayashi Y, Yamadori I, Fujita J, et al. 1997. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 112:1338-43
125. Cailes JB, O'Connor C, Pantelidis P, et al. 1996. Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis. Eur. Respir. J. 9:992-99
126. Martinet Y, Rom WN, Grotendorst GR, et al. 1987. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 317:202-9
127. Carre PC, Mortenson RL, King TE Jr., et al. 1991. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J. Clin. Invest. 88:1802-10
128. Nishida M, Fujinaka H, Matsusaka T, et al. 2002. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J. Clin. Invest. 110:1859-68
129. Oliver JA. 2002. Unexpected news in renal fibrosis. J. Clin. Invest. 110:1763-64
130. Bokel C, Brown NH. 2002. Integrins in development: moving on, responding to, and sticking to the extracellular matrix. Dev. Cell 3:311-21
131. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463-516
132. Collier IE, Wilhelm SM, Eisen AZ, et al. 1988. H-ras oncogene- transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263:6579-87
133. Pardo A, Ridge K, Uhal B, et al. 1997. Lung alveolar epithelial cells synthesize interstitial collagenase and gelatinases A and B in vitro. Int. J. Biochem. Cell Biol. 29:901-10
134. Johnson RJ, Couser WG, Chi EY, et al. 1987. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J. Clin. Invest. 79: 1379-87
135. Raats CJ, Bakker MA, van den Born J, et al. 1997. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J. Biol. Chem. 272:26734-41
136. Larios JM, Budhiraja R, Fanburg BL, et al. 2001. Oxidative protein cross-linking reactions involving L-tyrosine in transforming growth factor-β1-stimulated fibroblasts. J. Biol. Chem. 276:17437-41
137. Wright JK, Cawston TE, Hazleman BL. 1991. Transforming growth factor β stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. Biochim. Biophys. Acta 1094:207-10
138. Kunkel SL, Lukacs NW, Strieter RM, et al. 1996. Th1 and Th2 responses regulate experimental lung granuloma development. Sarcoidosis Vasc. Diffuse Lung Dis. 13:120-28
139. Gharaee-Kermani M, McGarry B, Lukacs N, et al. 1998. The role of IL-5 in bleomycin-induced pulmonary fibrosis. J. Leukoc. Biol. 64:657-66
140. 1. J. Exp. Med. 194:809-21
141. Liu X, Kohyama T, Wang H, et al. 2002. Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L1049-56
142. Oldroyd SD, Thomas GL, Gabbiani G, et al. 1999. Interferon-γ inhibits experimental renal fibrosis. Kidney Int. 56:2116-27
143. Ulloa L, Doody J, Massague J. 1999. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-γ/STAT pathway. Nature 397:710-13
144. Wallace WA, Ramage EA, Lamb D, et al. 1995. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin. Exp. Immunol. 101:436-41
145. Ando M, Miyazaki E, Fukami T, et al. 1999. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study. Respirology 4:383-91
146. Ziesche R, Hofbauer E, Wittmann K, et al. 1999. A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341:1264-69
147. Honore I, Nunes H, Groussard O, et al. 2003. Acute respiratory failure after interferon-γ therapy of end-stage pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 167:953-57
148. Folkman J, D'Amore PA. 1996. Blood vessel formation: What is its molecular basis? Cell 87:1153-55
149. Keane MP, Arenberg DA, Lynch JP 3rd, et al. 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J. Immunol. 159:1437-43
150. Keane MP, Belperio JA, Burdick MD, et al. 2001. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 164:2239-42
151. Koyama S, Sato E, Haniuda M, et al. 2002. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166:382-85
152. Lappi-Blanco E, Kaarteenaho-Wiik R, Soini Y, et al. 1999. Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized. Hum. Pathol. 30:1192-96
153. Lappi-Blanco E, Soini Y, Kinnula V, et al. 2002. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J. Pathol. 196:220-27
154. Renzoni EA, Walsh DA, Salmon M, et al. 2003. Interstitial vascularity in fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 167:438-43
155. Holgate ST, Peters-Golden M, Panettieri RA, et al. 2003. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J. Allergy Clin. Immunol. 111:518-34
156. Wilborn J, Bailie M, Coffey M, et al. 1996. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97:1827-36
157. Peters-Golden M, Bailie M, Marshall T, et al. 2002. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am. J. Respir. Crit. Care Med. 165:229-35
158. Lama V, Moore BB, Christensen P, et al. 2002. Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent. Am. J. Respir. Cell Mol. Biol. 27:752-58
159. 2 inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell Mol. Physiol. 281:L1257-63
160. Mio T, Liu XD, Adachi Y, et al. 1998. Human bronchial epithelial cells modulate collagen gel contraction by fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 274:L119-26
161. Kolodsick JE, Peters-Golden M, Larios J, et al. 2003. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am. J. Respir. Cell Mol. Biol. 29:537-44
162. Moore BB, Peters-Golden M, Christensen PJ, et al. 2003. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L342-49
163. Moore BB, Paine R 3rd, Christensen PJ, et al. 2001. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol. 167:4368-77
164. MacNee W, Rahman I. 1995. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 50(Suppl. 1):S53-58
165. Rahman I, Skwarska E, Henry M, et al. 1999. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radical Biol. Med. 27:60-68
166. Meyer A, Buhl R, Magnussen H. 1994. The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis. Eur. Respir. J. 7:431-36
167. Borok Z, Buhl R, Grimes GJ, et al. 1991. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338:215-16
168. Whyte M, Hubbard R, Meliconi R, et al. 2000. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphisms. Am. J. Respir. Crit. Care Med. 162:755-58
169. Pantelidis P, Fanning GC, Wells AU, et al. 2001. Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 163:1432-36
170. Yonemaru M, Kasuga I, Kusumoto H, et al. 1997. Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis. Eur. Respir. J. 10:2040-45
171. Stewart JP, Egan JJ, Ross AJ, et al. 1999. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 159:1336-41
172. Kelly BG, Lok SS, Hasleton PS, et al. 2002. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 166:510-13
173. Baumgartner KB, Samet JM, Coultas DB, et al. 2000. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. Am. J. Epidemiol. 152:307-15
174. Mullen J, Hodgson MJ, DeGraff CA, Godar T. 1998. Case-control study of idiopathic pulmonary fibrosis and environmental exposures. J. Occup. Environ. Med. 40:363-67
175. Baumgartner KB, Samet JM, Stidley CA, et al. 1997. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 155:242-48
176. Flaherty KR, Toews GB, Travis WD, et al. 2002. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur. Respir. J. 19:275-83
177. Nobukuni S, Watanabe K, Inoue J, et al. 2002. Cigarette smoke inhibits the growth of lung fibroblasts from patients with pulmonary emphysema. Respirology 7:217-23
178. Coultas DB, Zumwalt RE, Black WC, et al. 1994. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150:967-72
179. Shelton DN, Chang E, Whittier PS, et al. 1999. Microarray analysis of replicative senescence. Curr. Biol. 9:939-45
180. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408:239-47
181. Kudravi SA, Reed MJ. 2000. Aging, cancer, and wound healing. In Vivo 14:83-92
182. White ES, Lazar MH, Thannickal VJ. 2003. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J. Pathol. 201:343-54